PHARMACIELO LTD (PCLO.CA) Stock Income Statement
TSX-V:PCLO - TSX Venture Exchange - CA71716K1012 - Common Stock - Currency: CAD
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.60M | 1.54M | 5.31M | 1.95M | 2.65M | |||
| Cost Of Goods | 3.30M | 3.42M | 3.72M | 5.02M | 7.69M | |||
| Gross Profit | -701.90K | -1.88M | 1.59M | -3.07M | -5.04M | |||
| Operating Expenses | 5.94M | 8.67M | 12.12M | 20.89M | 36.76M | |||
| Selling, General, and Administrative Expenses | 5.68M | 8.31M | 11.66M | 19.37M | 32.76M | |||
| Operating Income | -6.64M | -10.56M | -10.53M | -23.96M | -41.80M | |||
| Interest Income/Expense | -3.61M | -2.75M | -2.80M | -1.10M | -113.10K | |||
| Other Income/Expense | 70.20K | 336.40K | 989.70K | -333.00K | 1.00M | |||
| Non Recurring Items | -3.85M | -3.33M | -2.18M | -1.24M | -2.85M | |||
| Income Before Taxes | -14.03M | -16.30M | -14.52M | -26.63M | -43.76M | |||
| Income Tax | N/A | N/A | N/A | N/A | N/A | |||
| Net Income | -14.03M | -16.30M | -14.52M | -26.63M | -43.76M | |||
| EBITDA | -5.31M | -9.14M | -8.95M | -22.70M | -40.23M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.08 | -0.10 | -0.10 | -0.18 | -0.39 | |||
| Non GAAP EPS | N/A | N/A | N/A | N/A | -0.35 | |||
| Statistics | ||||||||
| Gross Profit Margin | -27.03% | -122.09% | 29.93% | -158.00% | -189.77% | |||
| Profit Margin | -540.34% | -1057.05% | -273.46% | -1369.14% | -1648.74% | |||
| Operating Profit Margin | -255.84% | -684.67% | -198.30% | -1231.80% | -1574.90% | |||
All data in CAD